Abstract:Abstract Background Preeclampsia is a severe complication of pregnancy that can impose a significant economic burden and pose a serious threat to the health of both mothers and infants. Currently, there are no effective treatment methods for established preeclampsia other than delivering the placenta. Methods We performed differential analysis and weighted correlation network analysis (WGCNA) on RNA-seq datasets to identify highly associated blood system biomarkers in preeclampsia. The expression levels and potential predictive value of these biomarkers were validated through ELISA experiments. Subsequently, multiple bioinformatics analyses were conducted to predict the biological activities and gene mappings of the selected genes. The changes in the proportions of blood immune cells and abnormal cell-cell communication in the pathogenesis of preeclampsia were explored through analysis of single-cell transcriptomics data from blood samples. Potential candidate drugs were predicted using the DrugBank database. Results We identified and preliminarily validated the expression levels of F2R Like Trypsin Receptor 1 (F2RL1) and Granzyme H (GZMH) in maternal blood samples from preeclampsia through quantitative experiments. Gene Set Enrichment Analysis (GSEA) indicated that F2RL1 is involved in the regulation of classical signaling pathways, including Toll-like receptor signaling pathway, pattern recognition receptor signaling pathway, oxidative stress-induced intrinsic apoptotic signaling pathway, and vesicle targeting processes. GZMH is primarily involved in immune processes associated with natural killer cells and also regulates lymphocyte chemotaxis. Analysis of single-cell sequencing datasets revealed significant changes in T cells and hematopoietic Stem Cell Growth Factor (HSC G-CSF) in the maternal blood system during the pathogenesis of preeclampsia. Receptor-ligand analysis and protein-drug analysis highlighted the important role of aspirin in the treatment of preeclampsia, as well as the potential value of tyrosine kinase inhibitors in preeclampsia treatment. Conclusion: This study identified the preeclampsia biomarkers F2RL1 and GZMH, which showed good diagnostic value, and predicted their potential biological functions. The disrupted immune environment in the maternal blood system and potential therapeutic drugs were explored through single-cell transcriptomics data analysis. This research provides new insights for the prediction of preeclampsia and deepens our understanding of the changes in the maternal blood system's immune environment during preeclampsia. However, further laboratory work and multicenter clinical evidence are still needed to clarify the clinical prospects of these findings.

ceRNA Network and Functional Enrichment Analysis of Preeclampsia by Weighted Gene Coexpression Network Analysis

Bioinformatics-based Identification of Mirna-, Lncrna-, and Mrna-Associated Cerna Networks and Potential Biomarkers for Preeclampsia.

Characterization of the lncRNA-mediated ceRNA regulatory networks in preeclampsia by integrated bioinformatics

Identification of mRNA-, circRNA- and lncRNA- Associated ceRNA Networks and Potential Biomarkers for Preeclampsia From Umbilical Vein Endothelial Cells

A Weighted Gene Co-Expression Network Analysis for Identifying Hub Genes in Preeclampsia-Induced Intrauterine Growth Restriction

Integrated analysis of multiple microarray studies to identify novel gene signatures in preeclampsia

Exploring the ceRNA network involving AGAP2-AS1 as a novel biomarker for preeclampsia

Identification of LncRNA-miRNA-mRNA ceRNA network in hypoxia-induced HTR-8/SVneo cells for preeclampsia

Analysis of a Circrna-, Mirna-, and Mrna-Associated Cerna Network Reveals Potential Biomarkers in Preeclampsia a Cerna Network in Preeclampsia

Identification and Comparison of Circular RNAs in Preeclampsia

Prediction of Differentially Expressed Genes and a Diagnostic Signature of Preeclampsia Via Integrated Bioinformatics Analysis

Integrated analysis of microRNA and mRNA expression profiles in Preeclampsia

Single-Cell RNA Sequencing and Microarray Analysis Reveal the Role of Lipid-Metabolism-Related Genes and Cellular Immune Infiltration in Pre-Eclampsia and Identify Novel Biomarkers for Pre-Eclampsia

Mechanistic study of pre-eclampsia and macrophage-associated molecular networks: bioinformatics insights from multiple datasets

Identification Of Key Genes In Preeclampsia-Associated Trophoblast Cells Using Bioinformatics Analysis

Hierarchical lncRNA regulatory network in early-onset severe preeclampsia

Comprehensive microarray analysis of severe preeclampsia placenta to identify differentially expressed genes, biological pathways, hub genes, and their related non-coding RNAs

Identifying Key Genes and Drug Screening for Preeclampsia Based on Gene Expression Profiles

Bioinformatics Methods in Biomarkers of Preeclampsia and Associated Potential Drug Applications

Integration of Single-Cell Sequencing and Transcriptomic Analysis to Identify Novel Diagnostic Biomarkers for Preeclampsia and Explore Changes in Immune Cell Interactions

Identification and validation of an angiogenesis-related signature associated with preeclampsia by bioinformatic analysis